BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 836278)

  • 1. Effects of hydrocortisone on the hypercalcemia and plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in mice bearing the HSDM1 fibrosarcoma.
    Tashjian AH; Voelkel EF; Levine L
    Biochem Biophys Res Commun; 1977 Jan; 74(1):199-207. PubMed ID: 836278
    [No Abstract]   [Full Text] [Related]  

  • 2. Dietary menhaden oil lowers plasma prostaglandins and calcium in mice bearing the prostaglandin-producing HSDM1 fibrosarcoma.
    Tashjian AH; Voelkel EF; Robinson DR; Levine L
    J Clin Invest; 1984 Dec; 74(6):2042-8. PubMed ID: 6439740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma concentrations of 13,14-dihydro-15-keto-prostaglandin E2 in rabbits bearing the VX2 carcinoma: effects of hydrocortisone and indomethacin.
    Tashjian AH; Voelkel EF; Levine L
    Prostaglandins; 1977 Aug; 14(2):309-17. PubMed ID: 897222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of prostaglandins in the production of hypercalcemia by tumors.
    Tashjian AH
    Cancer Res; 1978 Nov; 38(11 Pt 2):4138-41. PubMed ID: 698957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Actions of growth factors on plasma calcium. Epidermal growth factor and human transforming growth factor-alpha cause elevation of plasma calcium in mice.
    Tashjian AH; Voelkel EF; Lloyd W; Derynck R; Winkler ME; Levine L
    J Clin Invest; 1986 Nov; 78(5):1405-9. PubMed ID: 3490496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandins, calcium metabolism and cancer.
    Tashjian AH; Voelkel EF; Goldhaber P; Levine L
    Fed Proc; 1974 Jan; 33(1):81-6. PubMed ID: 4203957
    [No Abstract]   [Full Text] [Related]  

  • 7. Humoral hypercalcemia of malignancy: a syndrome in search of a hormone.
    Gottleib S; Rude RK; Sharp CF; Singer FR
    Am J Med; 1982 Nov; 73(5):751-5. PubMed ID: 6291389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer.
    Tashjian AH; Voelkel EF; Levine L; Goldhaber P
    J Exp Med; 1972 Dec; 136(6):1329-43. PubMed ID: 4345106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdomyosarcoma-induced hypercalcemia in a nude mouse.
    Takeuchi T; Takeuchi H; Hoshino R; Ohmi K
    Cancer; 1982 Jul; 50(1):94-6. PubMed ID: 6952956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Humoral mechanisms in neoplastic hypercalcemia].
    Gennari C; Montagnani M; Nami R; Francini G
    Minerva Med; 1984 Feb; 75(6):235-9. PubMed ID: 6324038
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma prostaglandins in hypercalcemic patients with neoplastic disease.
    Demers LM; Allegra JC; Harvey HA; Lipton A; Luderer JR; Mortel R; Brenner DE
    Cancer; 1977 Apr; 39(4):1559-62. PubMed ID: 851945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma prostaglandin E in patients with cancer with and without hypercalcemia.
    Robertson RP; Baylink DJ; Metz SA; Cummings KB
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1330-5. PubMed ID: 1002818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated prostaglandin and indomethacin-responsive hypercalcemia in a patient with malignant pheochromocytoma.
    Uchida T; Kuwao S; Ishibashi A; Koshiba K
    J Urol; 1985 Oct; 134(4):712-3. PubMed ID: 4032577
    [No Abstract]   [Full Text] [Related]  

  • 14. Two cases of humoral hypercalcemia of malignancy complicating infantile fibrosarcoma.
    Hirschfeld R; Welch JJG; Harrison DJ; Kremsdorf R; Chawla A
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin-mediated hypercalcemia: a paraneoplastic syndrome.
    Seyberth HW
    Klin Wochenschr; 1978 Apr; 56(8):373-87. PubMed ID: 205705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E and hypercalcemia in breast carcinoma: only a tumor marker? A need for perspective.
    Caro JF; Besarab A; Flynn JT
    Am J Med; 1979 Feb; 66(2):337-41. PubMed ID: 218452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The site of VX2 tumor transplantation affects the development of hypercalcemia in rabbits.
    Hubbard WC; Hough AJ; Johnson RM; Oates JA
    Prostaglandins; 1980 Jun; 19(6):881-9. PubMed ID: 7384559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulatory effect of epidermal growth factor on prostaglandin E2 production in mouse fibrosarcoma cell line (HSDM1 C1).
    Hirata Y; Uchihashi M; Nakashima H; Fujita T; Matsukura S
    Horm Metab Res; 1985 Sep; 17(9):448-50. PubMed ID: 2995220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful treatment of hypercalcemia by indomethacin in mice bearing a prostaglandin-producing fibrosarcoma.
    Tashjian AH; Voelkel EF; Goldhaber P; Levine L
    Prostaglandins; 1973 Apr; 3(4):515-24. PubMed ID: 4729590
    [No Abstract]   [Full Text] [Related]  

  • 20. Prostaglandins and hypercalcemia of cancer.
    Robertson RP
    Med Clin North Am; 1981 Jul; 65(4):845-53. PubMed ID: 7278429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.